KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 101 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $688,000 | +417.3% | 148,000 | +462.7% | 0.00% | +300.0% |
Q4 2015 | $133,000 | +43.0% | 26,300 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $93,000 | -90.9% | 26,300 | -74.3% | 0.00% | -80.0% |
Q2 2015 | $1,023,000 | +137.4% | 102,500 | +207.9% | 0.01% | +66.7% |
Q4 2013 | $431,000 | -92.7% | 33,290 | -95.8% | 0.00% | -95.2% |
Q2 2013 | $5,891,000 | – | 788,620 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 1,312,006 | $16,990,000 | 16.50% |
VHCP Management, LLC | 1,000,273 | $12,954,000 | 6.97% |
Cormorant Asset Management, LP | 1,700,000 | $22,015,000 | 6.39% |
HARVEY CAPITAL MANAGEMENT INC | 890,500 | $11,531,000 | 4.76% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 859,672 | $11,133,000 | 2.50% |
Rhenman & Partners Asset Management AB | 400,000 | $5,180,000 | 2.03% |
SECTORAL ASSET MANAGEMENT INC | 2,758,950 | $35,728,000 | 1.54% |
NORTHPOINTE CAPITAL LLC | 1,289,711 | $16,701,000 | 1.47% |
Knoll Capital Management, LLC | 200,000 | $2,592,000 | 1.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,483,260 | $19,208,000 | 1.00% |